An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes

Diabetic Autonomic Neuropathy Clinical Trial

Official title:
Oxidative Stress and Cardiovascular Denervation in Diabetes: An Interventional Trial

Status Completed

Clinical Trial Summary

The focus of this project is cardiovascular diabetic autonomic neuropathy (DAN). DAN affects the nerves that control heart rate and blood flow to the heart in people with diabetes. DAN may cause problems with the rhythm of the heartbeat or decrease blood flow to the heart. Three medications will be tested for their effectiveness in DAN.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00116207
Study type	Interventional
Source	University of Michigan
Contact
Status	Completed
Phase	Phase 3
Start date	January 2000
Completion date	December 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02682901` - Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects	Phase 4
Terminated	`NCT02573519` - Gastrointestinal Motility Among Diabetes Patients	N/A
Completed	`NCT00919347` - The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction	N/A
Completed	`NCT03031834` - Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus	Phase 4
Recruiting	`NCT00752440` - Inspiratory Muscle Training in Patients With Autonomic Neuropathic	Phase 4